Drug and FDA News, June 2013

We’ve had a good discussion in the comments on the advocacy action to request another meeting with FDA. I asked FDA if they would be pursuing Guidance to Industry on ME/CFS drug development, and was told it is already underway. I updated the original post with the email response from Dr. Theresa Michele.

There are a few other FDA news items to share with you:


This entry was posted in Advocacy and tagged , , , , . Bookmark the permalink.

1 Response to Drug and FDA News, June 2013

  1. Kristina says:

    Thanks so much Jennie for keeping us up-to-date!

Comments are closed.